Understanding the precise chemical nature of intermediates is fundamental for R&D scientists involved in complex organic synthesis. This article focuses on the chemical profile of the pharmaceutical intermediate known by its CAS number 1358581-37-9, and often referred to by its synonym 2-Methoxy Canagliflozin. Its intricate structure, featuring a thiophene ring, a fluorophenyl group, and a substituted pyran moiety, makes it a valuable asset in modern medicinal chemistry.

The chemical formula for this intermediate is C25H27FO6S, with a molecular weight of approximately 474.54 g/mol. The specific stereochemistry, indicated by the (2S,3R,4S,5S,6R) configuration, is often critical for its biological activity or its role in directing further stereoselective synthesis steps. This level of detail is crucial for scientists aiming to replicate or modify known synthetic pathways or design novel molecular entities.

As a pharmaceutical intermediate, its primary application lies in the synthesis of Active Pharmaceutical Ingredients (APIs). While specific drug targets are often proprietary, compounds with similar structural motifs are explored for various therapeutic areas, suggesting a broad potential application spectrum for this intermediate. For researchers looking to purchase this compound, ensuring its purity and accurate characterization is paramount.

The reliability of chemical suppliers is directly linked to the quality of scientific research. When seeking to acquire intermediates like CAS 1358581-37-9, engaging with a reputable manufacturer, particularly one based in China with a strong focus on fine chemicals, is advisable. These suppliers often provide detailed analytical data, such as NMR, LC-MS, and HPLC reports, to confirm the compound's identity and purity. This transparency is essential for R&D scientists who depend on precise molecular building blocks.

For those in need of this specialized chemical, reaching out to a trusted supplier in China can provide access to high-quality material with detailed chemical information, facilitating efficient progress in their research and development projects. The availability of such intermediates at a reasonable price fuels innovation in the pharmaceutical industry.